Ocugen, Inc.OCGNEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Deep AnalysisCompare

Ocugen, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic diseases, including rare inherited retinal disorders and age-related eye conditions. It operates primarily in the North American market, with a pipeline covering gene therapies, biologics, and vaccine candidates targeting unmet medical needs.